Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

Matthew Goetz; Vera Suman

doi:10.1002/cncr.24827

Genetic polymorphisms of CYP2D610 and CYP2C192, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1007
Number of pages	1
Journal	Cancer
Volume	116
Issue number	4
DOIs	https://doi.org/10.1002/cncr.24827
State	Published - Feb 15 2010

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.24827

Cite this

@article{a7d79e69321b492a90caae242e38b034,

title = "Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen",

author = "Matthew Goetz and Vera Suman",

year = "2010",

month = feb,

day = "15",

doi = "10.1002/cncr.24827",

language = "English (US)",

volume = "116",

pages = "1007",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

AU - Goetz, Matthew

AU - Suman, Vera

PY - 2010/2/15

Y1 - 2010/2/15

UR - http://www.scopus.com/inward/record.url?scp=76249097524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76249097524&partnerID=8YFLogxK

U2 - 10.1002/cncr.24827

DO - 10.1002/cncr.24827

M3 - Letter

C2 - 20041480

AN - SCOPUS:76249097524

SN - 0008-543X

VL - 116

SP - 1007

JO - Cancer

JF - Cancer

IS - 4

ER -

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Genetic polymorphisms of CYP2D610 and CYP2C192, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen